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Do we need MR conditional pacemakers?
Abstract
Magnetic resonance imaging (MRI) is a widely accepted tool for the diagnosis of a variety of disease
states. However, due to safety concerns the presence of an implanted cardiac pacemaker is considered to
be a contraindication to MRI in most medical centres. The increasing number of implanted pacemakers
and the estimated over 50% probability that a pacemaker patient may be a candidate for an MRI
increase the need for safe scanning of pacemaker patients. Over the last ten years a major effort has been
made to understand the potential risks. The influences from the three electromagnetic fields on
pacemakers are versatile and will be summarised. The research in this area has helped to predict the
risks of an MRI scan in patients with conventional pacemakers, and has also stimulated pacemaker
manufacturers to improve their devices with the goal of providing MR conditional devices. Since
autumn 2008 the first approved MR conditional pacemakers have been on the market and other devices
are likely to follow this trend. However, the vast majority of devices are still not approved for MRI, a
situation which will take several years to change. It is thus important that a solution be also found for
these patients. Several studies including over 500 patients with a pressing need for MRI have been
performed at different experienced centres. On the basis of those data various organisations in MRI
fields have proposed guidelines for MRI in patients who fulfill given requirements. However, at present,
non- MRI modalities should be considered, whenever possible, for diagnosis in pacemaker recipients
with conventional devices. If other imaging modalities are not adequate, MRI with careful monitoring
and preparation for adverse events may be considered only at experienced centres. With the wider
availability of MR conditional devices, the risks of MRI are greatly reduced and non-tertiary centres will
be able to perform these investigations. In any case, rapid progress in the field of MR conditional pacing
is desirable.
Summary
Magnetic resonance imaging (MRI) is a widely accepted
tool for the diagnosis of a variety of disease states.
However, due to safety concerns the presence of an im-
planted cardiac pacemaker is considered to be a con-
traindication to MRI in most medical centres. The
increasing number of implanted pacemakers and the
estimated over 50% probability that a pacemaker pa-
tient may be a candidate for an MRI increase the need
for safe scanning of pacemaker patients. Over the last
ten years a major effort has been made to understand
the potential risks. The influences from the three elec-
tromagnetic fields on pacemakers are versatile and will
be summarised. The research in this area has helped to
predict the risks of an MRI scan in patients with con-
ventional pacemakers, and has also stimulated pace-
maker manufacturers to improve their devices with the
goal of providing MR conditional devices. Since autumn
2008 the first approved MR conditional pacemakers
have been on the market and other devices are likely to
follow this trend.
However, the vast majority of devices are still not
approved for MRI, a situation which will take several
years to change. It is thus important that a solution be
also found for these patients. Several studies including
over 500 patients with a pressing need for MRI have
been performed at different experienced centres. On
the basis of those data various organisations in MRI
fields have proposed guidelines for MRI in patients who
fulfill given requirements. However, at present, non-
MRI modalities should be considered, whenever possi-
ble, for diagnosis in pacemaker recipients with con-
ventional devices. If other imaging modalities are not
adequate, MRI with careful monitoring and prepara-
tion for adverse events may be considered only at ex-
perienced centres. With the wider availability of MR
conditional devices, the risks of MRI are greatly re-
duced and non-tertiary centres will be able to perform
these investigations. In any case, rapid progress in the
field of MR conditional pacing is desirable.




Magnetic resonance imaging (MRI) is the modality of
choice for a wide range of soft tissue pathologies. Since
the first live human images reported in 1977, the
development of clinical MRI has been rapid. Around
60 million MRI procedures are performed today [1]. On
the other hand, the number of implanted pacemakers
is increasing, with an estimated 50–75% probability of
MRI being indicated in a patient during the lifetime of
their device [2].
Various studies have shown that MRI may be haz-
ardous in patients with implanted pacemakers [3–8].
The greatest risk posed by MRI in pacemaker patients
is the reported lethal consequences in these patients
[9–12]. Six patients have died in Germany [13] but no
data are available from other countries. MRI is there-
fore considered a contraindication for recipients of
these devices at most MRI centers. However, there are
also reports of safe MRI if this diagnostic technique
was an absolute necessity [8, 14–20]. Based on the re-
sults of these studies, different organisations have pub-
lished guidelines stating that MRI may be acceptable
for selected patients with pacemakers.
Potential benefits of magnetic resonance
imaging in paced patients
In patients with permanent pacemakers MRI may con-
fer major diagnostic benefits since the technique has
advantages over other imaging modalities. MRI has
now become the imaging modality of choice for all
congenital, traumatic, hereditary, vascular, infectious,
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autoimmune, metabolic, and neoplastic disorders of the
central nervous system. It is the imaging modality of
choice for further evaluation of musculoskeletal disor-
ders, when physical examination or plain radiography
suggests a serious abnormality. Cardiovascular MRI is
useful in the evaluation of congenital and acquired
diseases of the heart and great vessels, and has been
a rapidly advancing area of clinical research [21].
Electromagnetic fields in magnetic resonance
imaging
MRI uses three different electromagnetic fields to
produce images. Themain static magnetic field is used
to align protons. This magnetic field is 0.5–3T strong
(~50000 times stronger than the earth’s magnetic field)
in most of the currently available MRI units for clinical
use, and is always on. The time-varying magnetic gra-
dient fields, used for spatial localisation, change their
strength along different orientations and operate at
frequencies up to 100 kHz. Clinical MRI systems have
a gradient strength of up to 80 mT/m with a slew rate
of up to 200 mT/m/ms. In current systems the usable
gradient power is limited by peripheral nerve stimula-
tion. The pulsed RF field, generated by the body-coil or
a send/receive head-coil, is used to change the energy
state of the protons and elicit MRI signals from tissue.
The RF field is switched on and off during measure-
ments. The frequency depends on the main magnetic
field with 42 MHz/T (= 21–128 MHz on current clini-
cal systems). The RF amplifiers have a power of up to
25 kW with a duty cycle of <10%.
Effects of magnetic resonance imaging
on cardiac pacemakers
The potential effects of MRI on cardiac pacemakers are
multiple (table 1) [3–6, 22]. MRI may involve the fol-
lowing potential risks for pacemaker patients:
The main magnetic field of the MRI scanner pro-
duces force and torque effects; however, with modern
pacemakers these effects are not harmful to the pa-
tients [23, 24]. On the other hand, in strong magnetic
fields above 200mT, the state of the reed switch is un-
predictable [25] and the pacemaker may stay in an
asynchronous mode or may revert to a synchronous
mode. This problem has been solved in some of the
newer devices by using semiconductor magnet switches
such as hall sensors.
The gradient as well as the RF field may mimic
cardiac signals if the pacemaker is in a synchronous
mode, and pacing may therefore be inhibited or trig-
gered by MRI. With the gradient field bipolar pacing is
safer, but this may not be the case with the RF field, a
problem which asynchronous pacing may solve. In
worst-case situations the induced voltages from the
gradient field and possibly from the RF-field are strong
enough to stimulate the heart. This can be prevented
by appropriate design of the pacemaker.
Some devices reset as the patient is moved into the
strong magnetic field, whereas others do so during im-
aging while the gradient and RF fields are active [26].
The reset programming may be inadequate for the pa-
tient undergoing MRI. Induced voltages in the device
will provoke vibrations in the static magnetic field.
This effect may be felt by the patient and may even
lead to wire fractures inside the device.
High electrical fields of the radiofrequency field
will induce currents which will drop over the ohmic re-
sistance of the lead tip-myocardium interface and de-
posit power, thus possibly destroying parts of the adja-
cent myocardial tissue. Figure 1 illustrates the poten-
tial risk of RF heating. The amount of absorbed RF
energy depends on several parameters such as lead po-
sition, lead construction, impedance at the lead tip and
Kardiovaskuläre Medizin 2010;13(2):70–74
Table 1
Potential effects of MRI on pacing systems.
Device (pacemaker or ICD) Lead





Destruction of an ICD in case
of high voltage charging




RF field Destruction of device circuits Heating effects
Pacemaker reprogramming





Discoloration of muscle tissue around the lead tip in an in vitro experi-
ment caused by a high RF power MRI scan for 3 minutes.
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at the device connector, position within the sending RF
coil, type of RF coil, power and duration of the RF
pulses and the frequency of the RF field. Since the ab-
sorbed power is a resonance effect, small changes in
lead configuration may result in a strong increase in
heating [27], making testing very challenging. The ef-
fects of electrode heating are not detectable by moni-
toring during MRI. However, an increase in pacing
threshold, arrhythmias caused by scar tissue or even
myocardial perforation are among the potential con-
cerns long after scanning, but such chronic effects of
MRI have not yet been studied.
Image artifacts induced by the pacing system could
be a problem for MRI. However, the image artifacts are
limited to 5–10 cm around the device. Most pacing
leads are non-magnetic and produce limited image ar-
tifacts.
Animal and human studies
Two published animal studies have shown controver-
sial results. In an acute study by Roguin et al. [28]
using a canine model and clinical scans with an SAR
of <1.4 W/kg, only minor heating could be observed. In
a chronic study [29] using 70 kg pigs allowing lead
placement comparable to that in humans, heating of
up to 20 °C (SAR up to 3.9 W/kg) at the lead tip could
be measured. The lead impedance was increased after
MRI. No reproducible histological alteration linked to
heating could be found. In one of the animals an ar-
rhythmia could be induced by high SAR levels (fig. 2).
There are a few anecdotal reports of unexpected
deaths in patients undergoing MRI [9–12]. In one case
the patient had no escape ventricular rhythm and ap-
parently died from asystole. Another patient developed
ventricular fibrillation during the imaging procedure
which was not recognised immediately since ECGmon-
itoring was not used [30]. It is likely that many poten-
tial complications go unreported in the literature for
various reasons (liability, etc.).
A number of human studies have been performed
to date in several hundred patients, the majority with
limitations to SAR, body regions imaged, type of de-
vices, etc., without severe problems [16, 19, 26, 31–33].
Some studies showed pacing threshold increases in
some of the patients which could be an indication of RF
heating of the heart tissue around the pacing lead tip.
In one of these studies a ventricular arrhythmia was
induced during scanning in a patient with significant
proximal stenosis of the right coronary artery. Thanks
to adequate monitoring and the presence of trained
personnel, the patient could be cardioverted success-
Kardiovaskuläre Medizin 2010;13(2):70–74
Figure 2
During an animal experiment using a conventional pacemaker system, a regular sustained ventricular tachycardia at ~240 bpm was observed.
A stable rhythm at 85 bpm resumed within a few seconds after the scan was stopped. This illustrates the potential risk of arrhythmia induction
in patients with pacemakers and the need for ECG monitoring during scanning (adapted from Luechinger et al. [29]).
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fully (private communication with Dr. Claas Philip
Nähle, Bonn). The results of anecdotal safe scans of pa-
tients are not sufficient to prove safety for MRI exam-
inations in patients with pacemakers.
A safety protocol for imaging of patients with per-
manent pacemaker and implantable cardioverter-de-
fibrillator (ICD) systems has been proposed by Nazar-
ian et al. in Baltimore [34]. This protocol may be help-
ful for a systematic approach to such patients.
However, the list of devices with previously satisfac-
tory testing needs to be approached with caution.
MRI in patients with conventional pacemakers
Different studies including over 500 safe scans in pace-
maker patients under controlled conditions afforded
grounds to revise several organisations’ guidelines and
change MRI from an absolute to a relative contraindi-
cation in pacemaker patients. Revised guidelines of the
following societies have been published: the ACR Blue
Ribbon Panel on MR Safety [35], the European Heart
Rhythm Association and Working Group on Cardio-
vascular Magnetic Resonance of the European Society
of Cardiology (EuroCMR) [36], theAmerican College of
Cardiology Foundation, the NorthAmerican Society for
Cardiac Imaging, and the Society for Cardiovascular
Magnetic Resonance [37].
The recommendations may differ slightly on details
such as the preferred pacing mode during an MRI in-
vestigation, but there is a high degree of agreement on
some important points:
– Consensus by the radiologist and cardiologist on
the need for MR imaging without an imaging al-
ternative. The higher risk of pacemaker-dependent
patients must be taken into account.
– Pacemaker patients should only be scanned at ex-
perienced centres with expertise in MR imaging
and electrophysiology.
– If abandoned endocardial and/or epicardial leads
are present, reconsider the need for MRI; minimise
SAR and avoid the thoracic region.
– A person with expertise in MRI physics and safety
should be involved with the scan to ensure optimal
planning of the MRI procedure to minimise risk,
and consideration should be given to using scan-
ning parameters that are believed to minimise
study risk (e.g., lowest RF power levels, weak-
est/slowest necessary gradient magnetic fields
etc.).
– The pacemaker must be programmed to OFF; i.e.,
sensing (monitoring)-only mode [OAO, OVO, ODO]
or to subthreshold outputs in patients with a reli-
able intrinsic rhythm. Lead polarity should if pos-
sible be programmed to bipolar. Additional diag-
nostic functions such as magnet response, rate re-
sponse, ventricular rate regulation and capture
management features will need to be disabled. In
pacemaker-dependent patients an asynchronous
mode should be programmed (VOO or DOO).
– The patient should be monitored by ECG and pulse
oximetry during the entire exam.
– An advanced cardiac life support (ACLS)-certified
physician should be present at the MRI console
during the entire examination to monitor the pa-
tient and perform basic and ACLS if needed. A
crash cart with an external defibrillator must be
present at the MR scanner.
– After completion of the MRI study, the device
should be re-interrogated and the parameters re-
programmed to the original settings. Sensing and
pacing thresholds should be measured and re-
peated 1 week and 3 months after the exam.
MR conditional pacemaker
An MR conditional pacemaker can undergo an MRI
investigation under conditions provided by the pace-
maker manufacturer such as maximum SAR levels,
allowed field strengths, excluded body regions, etc.
Ideally, devices would even be MR safe. However, this
definition implies that the device may be safely exposed
to MRI under any future conditions. As long as the pac-
ing systems contain conducting wires, this will never
be the case. This is why pacing systems are only
termed MR conditional.
The CE mark approval was received for the first
MR conditional pacemaker in the fall of 2008 (the
Medtronic Enrhythm™ MRI Surescan™ pacemaker).
This system has been modified to reduce interactions
with MRI electromagnetic fields. After extended in-
vitro and animal testing, a clinical study
1
has been per-
formed on over 240 patients worldwide who underwent
different MRI scans of the head and the lumbar spine.
The first MR imaging was successfully performed on
April 10th, 2007 (University Hospital Zurich, Switzer-
land). The study showed no difference in different pac-
ing parameters pre- and post-MRI compared with the
control group. No evidence of clinical (bradycardia or
tachycardia), subclinical (pacemaker performance) or
technical (pacemaker or lead damage) adverse events
was observed in patients receiving MRI.
Future directions for magnetic resonance
imaging compatible pacing
The future of MR conditional pacing systems seems to
be bright. New MR conditional pacemaker models are
likely to follow and it is hoped that restrictions con-
cerning body regions to be imaged will be withdrawn
for the future generation of devices. Since the vast ma-
jority of the currently implanted leads are conventional
leads, these patients may only benefit from new devel-
opments if the old leads are removed. However, ex-
tracting old leads may also pose significant risks.
Kardiovaskuläre Medizin 2010;13(2):70–74
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The combined use of individual components of pre-
viously MR conditional systems (e.g., a pacemaker from
one manufacturer and a pacing lead from another) will
not necessarily be MR conditional as a combination.
Even if only MR conditional devices were implanted in
the future, this would not necessarily mean that all pa-
tients may be imaged safely. Patients with damaged or
abandoned MR conditional leads may not be safely
scanned.
Conclusions
The availability of MR conditional pacemakers is an
important step in the right direction. However, it is
likely to take several years until only MR conditional
systems will be implanted. The published guidelines
may help in performing MRI in patients with older
pacemaker systems, if this imaging modality is an ab-
solute diagnostic necessity.
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